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Conclusions 
TP73 is a member of the TP53 family of proteins that acts as a 
transcription factor to help regulate cellular distress. This tumor 
protein may play a dual role as a tumor suppressor and tumor 
promoter. The TP73 gene is mapped to chromosome 1p36, a 
frequently deleted region in neuroblastoma and other types of 
tumors. Neuroblastoma is typically a childhood cancer that 
begins in the nerve tissue atop the adrenal gland of kidneys. 
Cancer is characterized by uncontrollable cell proliferation 
stemming from the accumulation of many mutations that develop 
over a long period of time. 
Our studies revealed that TP73 was expressed in neuroblastoma 
cells but not in non-cancerous cells as a result of silencing by 
DNA methylation. In conclusion, the absence of TP73 in normal 
cells is in part due to DNA methylation implying that TP73 plays a 
role in the promotion and/or progression of carcinogenesis. 
Normal fibroblasts and tumor kidney cells were grown at 37°C in 
5% CO2 in their respective growth media.  DNA and RNA of both 
cell types were extracted using standard procedures. RNA 
expression was analyzed by RT-PCR and DNA methylation was 
analyzed by bisulfite sequencing. The expressions of TP73 gene 
and its protein were analyzed by gel electrophoresis and 
immunohistochemistry respectively.  
To examine the role of TP73 in the formation of neuroblastoma
The TP73 gene was expressed in all of the neuroblastoma 
cells but not in the normal cell lines. This was due to the 
methylation of TP73 promoter in the normal cell lines. 
Figure 1. Immunohistochemical analyses of 
TP73 protein expression in healthy and 
neuroblastoma tissues.  
Figure 3. Methylation status of the expression 
of TP73 gene in normal and neuroblastoma 
cell lines.   
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Figure 2. mRNA levels in Neuroblastoma cell 
lines (IMR32 and SK-N-SH) compared to 
normal fibroblast  cell lines (HS27). 
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